Concurrent hormone therapy may augment the cardiometabolic benefits of tirzepatide, including improved blood pressure and lipid profiles.

The WHO released its first guideline on the prevention, diagnosis, and treatment of male- and female-factor infertility.

Girls with central precocious puberty (CPP) and premature thelarche exhibit distinct DXA-based body composition and bone density patterns.

GLP-1RA therapy vs metformin may offer time-dependent neuroprotection against Parkinson disease among patients with type 2 diabetes.

Wildfire smoke exposure during pregnancy may increase the risk for autism spectrum disorder (ASD), according to a new study.

The AMA and the Vaccine Integrity Project at the University of Minnesota are creating a system to review scientific evidence ...

Nutritional interventions, particularly supplements, are associated with significant improvements in anxiety among patients with T2D.

Patients undergoing gender-affirming vaginoplasty experience worsening of OAB with respect to their health-related quality of life (HRQoL).

The US Food and Drug Administration (FDA) is relaxing a long-standing drug approval requirement for common diseases.

The risk for nonscarring hair loss (NSHL) is increased in association with glucagon-like peptide-1 receptor agonist (GLP-1 RA) use.

Phase 3 PEACE trial data support the accelerated approval of Loargys for the treatment of arginase 1 deficiency in pediatric and adult patients.

SSRI medication use during pregnancy may increase the risk for GD and some poor newborn outcomes, but may protect against adverse outcomes.